What Is Melanotan I?
Melanotan I is a melanocortin peptide supplied by Peptegrity for research and educational purposes. This page provides a factual educational overview of Melanotan I, including its classification, biological target, research background, terminology and published study context. It is not a product page and does not provide dosing instructions, treatment recommendations or personal-use guidance.
Type of compound
Melanotan I is a synthetic analogue of the naturally occurring peptide hormone alpha-melanocyte stimulating hormone (alpha-MSH). It is classified as a melanocortin peptide, which acts upon specific receptors involved in pigmentation processes.
Biological target and mechanism
The compound functions as a melanocortin receptor agonist, specifically targeting the melanocortin-1 receptor (MC1R). By activating these receptors, research investigates how the compound modulates the production of melanin in melanocytes [2].
Research background
Melanotan I was developed as a synthetic peptide to study the physiological pathways of skin pigmentation and its response to ultraviolet radiation. Early research focused on evaluating whether synthetic analogues could induce a tanning response in human volunteers [1].
Current research and development status
Melanotan I remains an investigational compound utilized strictly in laboratory and clinical research settings. It is not currently an FDA- or TGA-approved therapeutic agent for human medical use.
Published research context
Published studies have evaluated the pharmacokinetics and delivery methods for alpha-MSH analogues in a laboratory context [4]. Clinical investigations have monitored human volunteers to observe physiological responses following exposure to the peptide in conjunction with UV radiation [1]. Other reports have discussed the historical development and clinical milestones of melanocortin therapeutics [2], as well as longitudinal case studies identifying dermatological developments requiring further investigation [3].
Relevant terminology
Melanocortin receptors are a group of G-protein coupled receptors found throughout the body, including the skin. Alpha-MSH is an endogenous peptide that plays a regulatory role in melanin synthesis, and synthetic analogues are chemical variations designed for scientific study.
Storage and handling terminology
In a research environment, lyophilized peptides like Melanotan I are typically stored in airtight containers at sub-zero temperatures (e.g., -20°C or -80°C) to maintain stability. Proper handling involves sterile technique and reconstitution in appropriate analytical buffers for experimental use.
Testing and Certificate of Analysis (COA)
A Certificate of Analysis (COA) is a document provided by manufacturers to confirm the purity, identity, and safety profile of a research chemical. Researchers typically verify these documents to ensure the peptide meets the analytical standards required for consistent experimental outcomes.
Regulatory status
Melanotan I is considered a research chemical and has not received regulatory approval for the diagnosis, cure, or prevention of any disease. It is strictly limited to authorized laboratory research and industrial development purposes.
This page is for research and educational purposes only. It is not intended to provide medical advice, dosing instructions, or treatment recommendations, and does not represent any product as approved to diagnose, treat, cure or prevent any disease. Compounds described here may be investigational or unapproved medicines; regulatory status is summarised for information only.
Frequently asked questions
What is Melanotan I?
Melanotan I is a synthetic linear peptide that functions as a structural analogue to the endogenous hormone alpha-melanocyte stimulating hormone (alpha-MSH).
How is Melanotan I classified?
It is classified as a melanocortin peptide, specifically functioning as a potent agonist at the melanocortin-1 receptor (MC1R).
What is the regulatory status of Melanotan I?
Melanotan I is an investigational substance and is not approved by major regulatory agencies such as the FDA or TGA for clinical or medical use.
What areas of research utilize Melanotan I?
Research into Melanotan I primarily focuses on the physiological mechanisms of melanogenesis, receptor-binding affinities, and the development of controlled-release delivery systems for peptides [1][4].
References
- 1.Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteersPubMed
- 2.Melanocortin peptide therapeutics: historical milestones, clinical studies and commercializationPubMed
- 3.Melanotan-associated melanoma in situPubMed
- 4.Controlled-release delivery system for the alpha-MSH analog melanotan-IPubMed
